Mpox Antiviral Clinical Trial Advances as WHO Extends Global Emergency Medical Countermeasures July 17, 2025 …
Peptide-Based Monkeypox Vaccine Candidate Designed Using Viral Glycoprotein Target Medical Countermeasures July 14, 2025 …
New Multi-Epitope Mpox Vaccine Shows Strong Potential in Silico Medical Countermeasures July 8, 2025 …
Monkeypox Virus Disarms the Body’s Immune Alarm: New Study Uncovers Viral Sabotage Tactic Pathogens July 6, 2025 …
W.H.O. Partner Program Allocates 238,000 Doses of Mpox Vaccine to Four Countries Medical Countermeasures March 19, 2025 …
Tecovirimat Shown to Lack Efficacy as Treatment for Clade II Mpox Medical Countermeasures March 12, 2025 …
Disappointing Results for Tecovirimat Mpox Trial in the DRC Medical Countermeasures August 15, 2024 …
A Clear Picture of Poxvirus Cores Could Help Build Better Countermeasures Research February 5, 2024 …
NanoViricides’ Phase 1 Broad-Spectrum Antiviral Highly Effective for Mpox and Smallpox Medical Countermeasures November 14, 2023 …
Smallpox Vaccines: Bavarian Nordic Awarded Another Contract to Supply EU Strategic Reserve Medical Countermeasures September 13, 2023 …
Treatments for Poxviruses May Already Exist in Licensed Drugs Medical Countermeasures August 9, 2023 …
Smallpox Countermeasures: U.S. Awards $138M to Siga Technologies for TPOXX Industry News July 27, 2023 …
Does the Current Monkeypox Outbreak Qualify as an Epidemic, PHEIC, or Pandemic? Outbreak News July 15, 2022 …
